InsiderTrades

Form 4 for AVIR Atea Pharmaceuticals, Inc.

Accepted 2025-06-24 00:00:00 ET · period of report 2025-06-20 · accession 0000950170-25-089607 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-06-24 2025-06-20 AVIR Murphy Polly A. Dir M - OptEx $0.00 +29.6K 86.0K +52% $0
DM 2025-06-24 2025-06-20 AVIR Murphy Polly A. Dir A - Grant $0.00 +70.8K 29.6K New $0
D 2025-06-24 2025-06-20 AVIR Murphy Polly A. Dir M - OptEx $0.00 -29.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-06-20 M A 29,600 $0.00 86,045 D — — (F1) Restricted stock units convert into common stock on a one-for-one basis.
2 Derivative Stock Option (Right to Buy) 2025-06-20 A A 41,200 $0.00 41,200 D $3.25 · — to 2035-06-19 41,200 Common Stock (F3) The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 20, 2025, such that the option shall be fully vested on the first anniversary of the date of grant, subject to the Reporting Person's continued service through each such vesting date.
3 Derivative Restricted Stock Units 2025-06-20 M D 29,600 $0.00 0 D — · — to — 29,600 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F4) The restricted stock units were fully vested as of June 20, 2025
4 Derivative Restricted Stock Units 2025-06-20 A A 29,600 $0.00 29,600 D — · — to — 29,600 Common Stock (F1) Restricted stock units convert into common stock on a one-for-one basis. (F2) The restricted stock units vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant or (ii) the first anniversary of the date of grant, in each case, subject to the Reporting Person's continued service through the applicable vesting date.